JPM 2021_Atlanthera


How great starting this year with JPM Morgan event from January 11th to 15th! [...]
Bio Europe Spring 2020


Glad to attend Bio Europe Spring initially planned in Paris and now delivered digitally. Looking forward to fruitful dis [...]
Publication ODD ATA 2019

Orphan Drug Designation for our compound 12b80 in Osteosarcoma indication by EMA – Atlanthera

Our team is particularly proud and glad to announce the obtention of Orphan Drug Designation for our compound 12b80 in O [...]
BIO-Europe 2019

Bio Europe – Hamburg – November 2019

Our team will attend Bio Europe in Hamburg, Germany, from November 11th to 13th. Looking forward to discussing with you [...]
bio boston

Bio Convention – Boston – June 2018

Our team is delighted about attending BIO International Convention in Boston, MA, from June 4th to 7th. A great opportun [...]

New partnership with Dr Shelly Lawson Team – The University of Sheffield, UK

We are pleased to announce our new collaboration with Dr. Shelly Lawson research team in the department of oncology at t [...]
Best Wishes from Atlanthera Bone Research

Best wishes for 2018

Atlanta Group and Atlanthera’s Team wish you success and pleasure in your projects in 2018! We will keep going on our [...]

1st Sheffield Workshop of Translational Research in Bone Sarcoma – June 2017

Meet Atlanthera at the 1st Sheffield Workshop of Translational Research in Bone Sarcoma – 19-20 June 2017 in Sheff [...]

Meet2Win 2017

MATWIN organises in Bordeaux on May 11th and 12th 2017 the 3rd edition of MEET2WIN, French Business Convention entirel [...]
Labiotech map Atlanthera

Atlanthera listed on LABIOTECH MAP

ATLANTHERA is now part of the 960 European Biotech Companies listed on the Labiotech Map! -Founded in 2011 -Employees: 1 [...]
fight bone cancer and metastases

Atlanthera veut lever 5 millions pour son traitement contre les cancers osseux

Paru dans le Journal des Entreprises – Par Amandine Dubiez, le 19 janvier 2017 C’est potentiellement un marché [...]

First clinical test on patients for Atlanthera in 2017

24-01- 2017 Atlanthera is now preparing its first clinical tests on patients for the end of the year 2017. Phase I tests [...]

Meet Atlanthera Team during BIO-Europe in Cologne in November

Atlanthera Team will be participating BIO-Europe event in Cologne, from November 7th to 9th. Visit us on the booth 74, A [...]
bone targeted treatment in video

Discover Atlanthera concept in video

Atlanthera is pleased to present you its concept of bone targeted drug delivery through this video. Watch it now and dis [...]

Matwin French Oncology Business Convention, Bordeaux, May 2016

Come and meet us in Bordeaux next May 11th and 12th 2017 the 3rd edition of MATWIN and MEET2WIN, French Business Conve [...]